Apogee Therapeutics Inc (APGE)

Aug 12, 2025

Apogee Therapeutics Faces Supply Chain Risks Amid Geopolitical Tensions and Regulatory Challenges - MSN

Aug 12, 2025

Aug 12, 2025

Apogee Therapeutics Reports Promising Trial Results and Strong Cash Position - TipRanks

Aug 12, 2025

Aug 11, 2025

Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results - GlobeNewswire

Aug 11, 2025

Aug 11, 2025

Apogee Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2025

Aug 11, 2025

Apogee Therapeutics Q2 2025: A Catalyst-Driven Path to Re-Rating - AInvest

Aug 11, 2025

Aug 11, 2025

Apogee Therapeutics stock holds steady as Goldman Sachs reiterates rating - Investing.com

Aug 11, 2025

Aug 11, 2025

Apogee Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 11, 2025

Aug 11, 2025

Apogee Therapeutics provides pipeline progress and reports second quarter 2025 financial results - MarketScreener

Aug 11, 2025

Aug 11, 2025

Apogee Therapeutics Provides Pipeline Progress And Reports Second Quarter 2025 Financial Results - TradingView

Aug 11, 2025

Aug 11, 2025

Apogee Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 11, 2025

Aug 11, 2025

Apogee Therapeutics Q2 Net Loss Widens - MarketScreener

Aug 11, 2025

Aug 11, 2025

Apogee Therapeutics Q2 2025 Financial Results and Pipeline Progress - TradingView

Aug 11, 2025

Aug 11, 2025

Breakthrough: Apogee's New Atopic Dermatitis Drug Achieves 71% Efficacy with 6-Month Dosing Potential - Stock Titan

Aug 11, 2025

Aug 08, 2025

Apogee Therapeutics APGE Q2 2025 Earnings Preview Upside Potential Hinges on Strategic Partnerships - AInvest

Aug 08, 2025

Aug 08, 2025

Apogee Therapeutics CMO Carl Dambkowski Sells Shares - TradingView

Aug 08, 2025

Aug 07, 2025

This Apogee Therapeutics Insider Increased Their Holding In The Last Year - 富途牛牛

Aug 07, 2025

Aug 06, 2025

Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High? - Yahoo Finance

Aug 06, 2025

Aug 03, 2025

What are the latest earnings results for Apogee Therapeutics Inc.Outstanding capital returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is Apogee Therapeutics Inc. stock expected to show significant growthDouble or triple returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Apogee Therapeutics Inc. a growth stock or a value stockFastest-growing stock picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Apogee Therapeutics Inc. stockAchieve consistent profits with proven methods - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate Apogee Therapeutics Inc. as a “Buy”Maximize your returns with expert insights - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Apogee Therapeutics Inc. a good long term investmentInvest smarter with expert stock picks - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Should I hold or sell Apogee Therapeutics Inc. stock in 2025Free Stock Selection - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is it the right time to buy Apogee Therapeutics Inc. stockAchieve consistent double-digit growth rates - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Apogee Therapeutics, Inc. (APGE) Soars on Promising Phase 2 Results for Atopic Dermatitis Drug - MSN

Aug 02, 2025

Jul 31, 2025

How volatile is Apogee Therapeutics Inc. stock compared to the marketChart Pattern Updates For Fast Growth - Jammu Links News

Jul 31, 2025

Jul 31, 2025

What’s next for Apogee Therapeutics Inc. stock priceTop Performing Stock Insights Released Daily - metal.it

Jul 31, 2025

Jul 30, 2025

11 Best Future Stocks to Buy Now - Insider Monkey

Jul 30, 2025

Jul 30, 2025

Published on: 2025-07-30 23:15:33 - metal.it

Jul 30, 2025

Jul 30, 2025

Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma - MSN

Jul 30, 2025

Jul 29, 2025

Earnings visualization tools for Apogee Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser

Jul 29, 2025

Jul 29, 2025

Multi Factor Analysis Ranks Apogee Therapeutics Inc. as Strong BuyIntraday Trend Analysis for Fast Gains Released - metal.it

Jul 29, 2025

Jul 29, 2025

Order Book Volume Tilts Bullish on Apogee Therapeutics Inc.Trade Ready Stock Watch for Short Term Published - metal.it

Jul 29, 2025

Jul 27, 2025

Is Apogee Therapeutics Inc. stock overvalued or undervaluedFind the best stocks for sustainable growth - Jammu Links News

Jul 27, 2025

Jul 27, 2025

What makes Apogee Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser

Jul 27, 2025

Jul 27, 2025

Intrinsic Value of Apogee Therapeutics Inc. Stock: Is It Undervalued or OvervaluedFree Elite Traders Group - Newser

Jul 27, 2025

Jul 25, 2025

What analysts say about Apogee Therapeutics Inc. stockOver 200% growth - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What drives Apogee Therapeutics Inc. stock priceDynamic growth stocks - Autocar Professional

Jul 25, 2025

Jul 25, 2025

Apogee Therapeutics Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional

Jul 25, 2025

Jul 24, 2025

What makes Apogee Therapeutics Inc. stock attractive to long term investorsDynamic growth stocks - Jammu Links News

Jul 24, 2025

Jul 22, 2025

InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics By Investing.com - Investing.com Canada

Jul 22, 2025